![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MRPL38 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Mrpl38 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL38 mRNA | CTD | PMID:36331819 | MRPL38 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MRPL38 mRNA | CTD | PMID:22206623 | MRPL38 | Human | 17beta-estradiol | decreases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of MRPL38 mRNA | CTD | PMID:32145629 | MRPL38 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPL38 mRNA | CTD | PMID:21215274 and PMID:32109520 | MRPL38 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MRPL38 mRNA | CTD | PMID:33387578 | MRPL38 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPL38 mRNA | CTD | PMID:21570461 | MRPL38 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPL38 mRNA | CTD | PMID:22298810 | MRPL38 | Human | 2,4,6-trinitrotoluene | affects expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Trinitrotoluene affects the expression of MRPL38 mRNA | CTD | PMID:21346803 | MRPL38 | Human | 2,4-dinitrotoluene | affects expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of MRPL38 mRNA | CTD | PMID:21346803 | MRPL38 | Human | 2,6-dinitrotoluene | affects expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of MRPL38 mRNA | CTD | PMID:21346803 | MRPL38 | Human | 3H-1,2-dithiole-3-thione | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of MRPL38 mRNA | CTD | PMID:19162173 | MRPL38 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of MRPL38 protein | CTD | PMID:34186270 | MRPL38 | Human | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of MRPL38 mRNA | CTD | PMID:21346803 | MRPL38 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL38 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPL38 mRNA | CTD | PMID:32699268 | MRPL38 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL38 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPL38 mRNA | CTD | PMID:32699268 | MRPL38 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of MRPL38 mRNA | CTD | PMID:33212167 | MRPL38 | Human | arsenite(3-) | increases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | arsenite results in increased expression of MRPL38 protein | CTD | PMID:37955338 | MRPL38 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MRPL38 mRNA | CTD | PMID:20106945 | MRPL38 | Human | beta-lapachone | decreases expression | EXP | | 6480464 | beta-lapachone results in decreased expression of MRPL38 mRNA | CTD | PMID:38218311 | MRPL38 | Human | bisphenol A | decreases methylation | ISO | Mrpl38 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of MRPL38 promoter | CTD | PMID:27312807 | MRPL38 | Human | bisphenol AF | increases expression | EXP | | 6480464 | bisphenol AF results in increased expression of MRPL38 protein | CTD | PMID:34186270 | MRPL38 | Human | bisphenol F | decreases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of MRPL38 mRNA | CTD | PMID:38685157 | MRPL38 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL38 mRNA | CTD | PMID:35301059 | MRPL38 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL38 mRNA | CTD | PMID:35301059 | MRPL38 | Human | chlorpyrifos | increases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MRPL38 mRNA | CTD | PMID:37019170 | MRPL38 | Human | choline | multiple interactions | ISO | Mrpl38 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MRPL38 mRNA | CTD | PMID:20938992 | MRPL38 | Human | chromium(6+) | affects expression | ISO | Mrpl38 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of MRPL38 mRNA | CTD | PMID:28472532 | MRPL38 | Human | ciguatoxin CTX1B | affects expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of MRPL38 mRNA | CTD | PMID:18353800 | MRPL38 | Human | clofibrate | decreases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of MRPL38 mRNA | CTD | PMID:17585979 | MRPL38 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of MRPL38 mRNA | CTD | PMID:19549813 | MRPL38 | Human | corosolic acid | decreases expression | EXP | | 6480464 | corosolic acid results in decreased expression of MRPL38 mRNA | CTD | PMID:37939859 | MRPL38 | Human | dibutyl phthalate | decreases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of MRPL38 mRNA | CTD | PMID:21266533 | MRPL38 | Human | doxorubicin | decreases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Doxorubicin results in decreased expression of MRPL38 mRNA | CTD | PMID:19915844 | MRPL38 | Human | epoxiconazole | decreases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of MRPL38 mRNA | CTD | PMID:35436446 | MRPL38 | Human | finasteride | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of MRPL38 mRNA | CTD | PMID:24136188 | MRPL38 | Human | flutamide | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of MRPL38 mRNA | CTD | PMID:24136188 | MRPL38 | Human | folic acid | multiple interactions | ISO | Mrpl38 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MRPL38 mRNA | CTD | PMID:20938992 | MRPL38 | Human | gentamycin | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of MRPL38 mRNA | CTD | PMID:33387578 | MRPL38 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of MRPL38 protein | CTD | PMID:32959892 | MRPL38 | Human | L-methionine | multiple interactions | ISO | Mrpl38 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MRPL38 mRNA | CTD | PMID:20938992 | MRPL38 | Human | menadione | increases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Vitamin K 3 results in increased expression of MRPL38 mRNA | CTD | PMID:25270620 | MRPL38 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MRPL38 mRNA | CTD | PMID:28801915 | MRPL38 | Human | nimesulide | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of MRPL38 mRNA | CTD | PMID:24136188 | MRPL38 | Human | nitrates | multiple interactions | ISO | Mrpl38 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MRPL38 mRNA | CTD | PMID:35964746 | MRPL38 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL38 mRNA more ... | CTD | PMID:32699268 | MRPL38 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mrpl38 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL38 mRNA | CTD | PMID:36331819 | MRPL38 | Human | perfluorooctanoic acid | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of MRPL38 mRNA | CTD | PMID:19162173 and PMID:35163327 | MRPL38 | Human | pirinixic acid | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of MRPL38 mRNA | CTD | PMID:19162173 | MRPL38 | Human | pirinixic acid | increases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of MRPL38 mRNA | CTD | PMID:18445702 and PMID:23811191 | MRPL38 | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of MRPL38 mRNA | CTD | PMID:28903501 | MRPL38 | Human | rotenone | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of MRPL38 mRNA | CTD | PMID:28374803 | MRPL38 | Human | sodium dodecyl sulfate | decreases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of MRPL38 mRNA | CTD | PMID:31734321 | MRPL38 | Human | Soman | decreases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of MRPL38 mRNA | CTD | PMID:19281266 | MRPL38 | Human | tetrachloroethene | decreases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of MRPL38 mRNA | CTD | PMID:28973375 | MRPL38 | Human | tetrachloromethane | affects expression | ISO | Mrpl38 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of MRPL38 mRNA | CTD | PMID:17484886 | MRPL38 | Human | thioacetamide | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of MRPL38 mRNA | CTD | PMID:34492290 | MRPL38 | Human | titanium dioxide | decreases methylation | ISO | Mrpl38 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MRPL38 gene | CTD | PMID:35295148 | MRPL38 | Human | trovafloxacin | decreases expression | ISO | Mrpl38 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of MRPL38 mRNA | CTD | PMID:35537566 | MRPL38 | Human | valdecoxib | increases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | valdecoxib results in increased expression of MRPL38 mRNA | CTD | PMID:24136188 | MRPL38 | Human | vinclozolin | decreases expression | ISO | Mrpl38 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of MRPL38 mRNA | CTD | PMID:23034163 | |